Patent Assignment
Reel/Frame 035421/0435
Merger and Change of Name
Recorded: 2015-04-13
Pages: 3
Assignors
SANTARIS PHARMA A/S
Executed: 2014-11-03
ROCHE INNOVATION CENTER COPENHAGEN A/S
Executed: 2014-11-03
Assignee
ROCHE INNOVATION CENTER COPENHAGEN A/S
FREMTIDSVEJ 3, HORSHOLM, DK2970, DENMARK
Covered Properties
(12)
Oligomeric Compounds for the Modulation Hif-1ALPHA Expression
Potent Lna Oligonucleotides for the Inhibition of Hif-1A Expression
Lna Antagonists Targeting the Androgen Receptor
Potent Lna Oligonucleotides for the Inhibition of Hif-1A Expression
Oligomeric Compounds for the Modulation of Hif-1ALPHA Expression
Lna Antagonists Targeting the Androgen Receptor
Oligomeric Compounds for the Modulation of Hif-1A Expression
Methods for Treating Androgen Receptor Dependent Disorders Including Cancers
Potent Lna Oligonucleotides for the Inhibition of Hif-1A Expression
Oligomeric Compounds for the Modulation of Hif-1A Expression
Oligomeric Compounds for the Modulation of Hif-1A Expression
Potent Lna Oligonucleotides for the Inhibition of Hif-1A Expression
Related Assignments
(15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 27, 2003
From: THRUE, CHARLOTTE ALBACK; HOG, ANJA MOLHART; KRISTJANSEN, PAUL E.G.
To: SANTARIS PHARMA A/S
Reel/Frame 014639/0220 →
Assignment of Assignor's Interest
Jul 6, 2006
From: WESTERGAARD, MAJKEN; THRUE, CHARLOTTE A.; RASMUSSEN, FRANK W.; HANSEN, HENRIK F.
To: SANTARIS PHARMA A/S
Reel/Frame 018088/0007 →
Assignment of Assignor's Interest
Jul 23, 2007
From: SANTARIS PHARMA A/S
To: ENZON PHARMACEUTICALS, INC
Reel/Frame 019589/0108 →
Assignment of Assignor's Interest
Jul 23, 2007
From: SANTARIS PHARMA A/S
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 019589/0140 →
Assignment of Assignor's Interest
Sep 21, 2007
From: SANTARIS PHARMA A/S
To: ENZON, INC.
Reel/Frame 019861/0738 →
Assignment of Assignor's Interest
Feb 27, 2009
From: WORM, JESPER
To: SANTARIS PHARMA A/S
Reel/Frame 022322/0932 →
Amended and Restated Assginment of 50% Interest to Enzon Pharmaceuticals, Inc. Effective July 26, 2006
Apr 5, 2009
From: SANTARIS PHARMA A/S
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 022505/0620 →
Assignment of Assignor's Interest
Feb 19, 2010
From: SANTARIS PHARMA A/S
To: ENZON PHARMACEUTICALS, INC.; SANTARIS PHARMA A/S
Reel/Frame 023962/0177 →
Assignment of Assignor's Interest
Oct 18, 2010
From: SANTARIS PHARMA A/S
To: ENZON PHARMACEUTICALS, INC.
Reel/Frame 025154/0710 →
Assignment of Assignor's Interest
Oct 18, 2010
From: THRUE, CHARLOTTE ALBAEK; HOG, ANJA MOLHART; KRISTJANSEN, PAUL E.G.
To: SANTARIS PHARMA A/S
Reel/Frame 025154/0605 →
Assignment of Assignor's Interest
Aug 25, 2014
From: ENZON PHARMACEUTICALS, INC.
To: SANTARIS PHARMA A/S
Reel/Frame 033600/0791 →
Assignment of Assignor's Interest
Apr 10, 2015
From: ENZON PHARMACEUTICALS, INC.
To: SANTARIS PHARMA A/S
Reel/Frame 035384/0923 →
Assignment of Assignor's Interest
Apr 10, 2015
From: ENZON PHARMACEUTICALS, INC.
To: SANTARIS PHARMA A/S
Reel/Frame 035383/0823 →
Corrective Assignment to Correct the Redacted Schedule of the Executed Assignment Document Previously Recorded at Reel: 035384 Frame: 0923. Assignor(S) Hereby Confirms the Assignment.
Feb 16, 2016
From: ENZON PHARMACEUTICALS, INC.
To: SANTARIS PHARMA A/S
Reel/Frame 037821/0938 →
Corrective Assignment to Correct Schedule of the Executed Inside the Assignment Document. Previously Recorded at Reel: 033600 Frame: 0791. Assignor(S) Hereby Confirms the Assignment.
Feb 16, 2016
From: ENZON PHARMACEUTICALS, INC.
To: SANTARIS PHARMA A/S
Reel/Frame 037847/0121 →